Lp-PLA2 Antibody

• Description:

  Lp-PLA2 Antibody_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

  Catalog number:	A2010035
  Lot number:	Batch Dependent
  Expiration date:	Batch Dependent
  Package Size:	1 mg
  Other names:	Lipoprotein-Associated phospholipase A2 antibody
  Supplied as:	Solution
  Concentration:	Batch Dependent
  Purification:	Chromatography on protein A Sepharose
  Immunogen:	Human Lp-PLA2
  Preservative:	0.05% sodium azide
  Storage:	2-8°C (short term), -20°C (long term). Avoid repeated freeze-thaw.
  Other Names	PLA2G7; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma);PAFAD; PAFAH; LP-PLA2; LDL-PLA2; platelet-activating factor acetylhydrolase; LDL-PLA(2);gVIIA-PLA2; PAF 2-acylhydrolase; PAF acetylhydrolase; group-VIIA phospholipase A2; LDL-associated phospholipase A2; lipoprotein-associated phospholipase A2; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase, Lp-PLA2 Monoclonal Antibody,Anti-Lp-PLA2 antibody

  _x000D_  _x000D_ _x000D_ References_x000D_

  _x000D_
  • Tian Y, Jia H, Li S, Wu Y, Guo L, Tan G, Li B. The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A2: A systematic review and meta-analysis. Medicine (Baltimore). 2017 Dec;96(51):e9413.
  _x000D_
  • Li D, Wei W, Ran X, Yu J, Li H, Zhao L, Zeng H, Cao Y, Zeng Z, Wan Z. Lipoprotein-associated phospholipase A2 and risks of coronary heart disease and ischemic stroke in the general population: A systematic review and meta-analysis. Clin Chim Acta. 2017 Aug;471:38-45.
  _x000D_
  • Sato M. When we have learned about the brain development from a disease-oriented study: DBZ regulates cortical cell positioning and neurite extension by sustaining the anterograde transport of Lis1/DISC1 through control of Ndel1 phosphorylation. Nihon Shinkei Seishin Yakurigaku Zasshi. 2016 Apr;36(2):43-50.
  _x000D_
  • Pashun RA, Frishman WH. Therapeutic Role of Innovative Anti-Inflammatory Medications in the Prevention of Acute Coronary Syndrome. ardiol Rev. 2015 Sep-Oct;23(5):252-60.
  _x000D_
  • Tellis CC, Tselepis AD. Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A‚ÇÇ (Lp-PLA‚ÇÇ) bound to LDL and HDL. Curr Pharm Des. 2014;20(40):6256-69.
  _x000D_
  • Dallmeier D, Koenig W. Strategies for vascular disease prevention: the role of lipids and related markers including apolipoproteins, low-density lipoproteins (LDL)-particle size, high sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA‚ÇÇ) and lipoprotein(a) (Lp(a)). Best Pract Res Clin Endocrinol Metab. 2014 Jun;28(3):281-94.
  _x000D_

• Short Description:

  Catalog #: A2010035 (1 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5

• CAS Number:

  9007-83-4